KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia

The prognostic value of RAS mutations has been systematically investigated in acute myeloid leukemia (AML). However, clinical significance of RAS expressions in AML remains poorly determined. To explore the clinical significance, we analyzed KRAS and NRAS expressions in 143 de novo AML patients by r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Zhou, Jing-Dong, Yao, Dong-Ming, Li, Xi-Xi, Zhang, Ting-Juan, Zhang, Wei, Ma, Ji-Chun, Guo, Hong, Deng, Zhao-Qun, Lin, Jiang, Qian, Jun
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630394/
https://ncbi.nlm.nih.gov/pubmed/29029494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19798
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares